Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA)

Part of paid clinical trials in Abbott Park, Illinois.

Sponsor
Abbott
Study ID
NCT00235885
Phase
PHASE3
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of the study is to assess the safety and clinical efficacy of adalimumab in active psoriatic arthritis (PsA) subjects when adalimumab is added to insufficient standard therapy including patients that have failed other TNF therapies

Key Dates

Start date
Jul 31, 2005
Status verified
Aug 2007

Study Design

Enrollment
445 participants
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Primary Outcome Measure

Safety parameters

Locations (1)

FacilityCityStateZIPSite coordinators
Global Medical Information - AbbottAbbott ParkIllinois60064-

Find similar trials in Abbott Park, IL

By condition
Psoriatic arthritis
By specialty
RheumatologyAutoimmune diseaseMusculoskeletal disorders
By research site
Global Medical Information - Abbott· Abbott Park, IL

Related Studies